Literature DB >> 11145967

Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.

J B Kim1, P A Sharp.   

Abstract

The CDK9-cyclin T kinase complex, positive transcription elongation factor b (P-TEFb), stimulates the process of elongation of RNA polymerase (Pol) II during transcription of human immunodeficiency virus. P-TEFb associates with the human immunodeficiency virus Tat protein and with the transactivation response element to form a specific complex, thereby mediating efficient elongation. Here, we show that P-TEFb preferentially phosphorylates hSPT5 as compared with the carboxyl-terminal domain of RNA Pol II in vitro. Phosphorylation of hSPT5 by P-TEFb occurred on threonine and serine residues in its carboxyl-terminal repeat domains. In addition, we provide several lines of evidence that P-TEFb is a CDK-activating kinase (CAK)-independent kinase. For example, CDK9 was not phosphorylated by CAK, whereas CDK2-cyclin A kinase activity was dramatically enhanced by CAK. Therefore, it is likely that P-TEFb participates in regulation of elongation by RNA Pol II by phosphorylation of its substrates, hSPT5 and the CTD of RNA Pol II, in a CAK-independent manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145967     DOI: 10.1074/jbc.M010908200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

1.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 3.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

4.  Molecular evidence for a positive role of Spt4 in transcription elongation.

Authors:  Ana G Rondón; María García-Rubio; Sergio González-Barrera; Andrés Aguilera
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

5.  CTD kinase I is involved in RNA polymerase I transcription.

Authors:  Céline Bouchoux; Guillaume Hautbergue; Sabrina Grenetier; Christophe Carles; Michel Riva; Valérie Goguel
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

6.  Identification of Regions in the Spt5 Subunit of DRB Sensitivity-inducing Factor (DSIF) That Are Involved in Promoter-proximal Pausing.

Authors:  Yijun Qiu; David S Gilmour
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

7.  Bur1 kinase is required for efficient transcription elongation by RNA polymerase II.

Authors:  Michael-Christopher Keogh; Vladimir Podolny; Stephen Buratowski
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution.

Authors:  Andreas Mayer; Julia di Iulio; Seth Maleri; Umut Eser; Jeff Vierstra; Alex Reynolds; Richard Sandstrom; John A Stamatoyannopoulos; L Stirling Churchman
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

9.  The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.

Authors:  Sonja Baumli; Graziano Lolli; Edward D Lowe; Sonia Troiani; Luisa Rusconi; Alex N Bullock; Judit E Debreczeni; Stefan Knapp; Louise N Johnson
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

10.  Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages.

Authors:  Li-Ying Liou; Christine H Herrmann; Andrew P Rice
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.